Literature DB >> 7512929

Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.

B K Sim1, J M Carter, C D Deal, C Holland, J D Haynes, M Gross.   

Abstract

A 42 amino acid peptide, Pf EBA-175 (1062-1103), also called EBA-peptide 4 of the 175-kDa Plasmodium falciparum sialic acid binding protein, a putative merozoite invasion ligand, has been shown to be a target of parasite growth inhibitory antibodies. We expressed and purified a recombinant protein, NS1-Pf EBA-175 (946-1133) which included the 42 amino acid peptide, and compared antibodies induced by immunization with the protein to antibodies raised against the 42 amino acid peptide. Sera from rabbits immunized with the recombinant protein and the synthetic peptide immunoprecipitated authentic EBA-175, and had comparable ELISA titers against peptide Pf EBA-175 (1062-1103). However, IFAT titers against infected erythrocytes and growth inhibitory activity were substantially higher in sera from animals immunized with the 42 amino acid synthetic peptide. Epitope mapping of the 42 amino acid peptide identified a 19 amino acid peptide, Pf EBA-175 (1069-1087), which blocked the ability of antibodies against the 42 amino acid peptide to (1) immunoprecipitate EBA-175, (2) bind to the 42 amino acid peptide in an ELISA, and (3) recognize infected parasites in an IFAT. Sera from rabbits immunized with the 19 amino acid peptide conjugated to KLH had excellent parasite growth inhibitory activity (at 1:5 serum dilution, 49.9 +/- 7.4%, mean +/- SD of three separate assays), but the activity was lower in each of the three assays than that of sera from rabbits immunized with the 42 amino acid peptide (67.8 +/- 24.8%). These data indicate that the activity of antibodies raised against the linear 42 amino acid peptide, Pf EBA-175 (1062-1103) are primarily, if not exclusively, directed against 19 of the 42 amino acids, and identify this region of Pf EBA 175 as a target for vaccine development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512929     DOI: 10.1006/expr.1994.1027

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  11 in total

1.  Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations.

Authors:  Alexander G Maier; Manoj T Duraisingh; John C Reeder; Sheral S Patel; James W Kazura; Peter A Zimmerman; Alan F Cowman
Journal:  Nat Med       Date:  2002-12-09       Impact factor: 53.440

2.  Polymorphisms in erythrocyte binding antigens 140 and 181 affect function and binding but not receptor specificity in Plasmodium falciparum.

Authors:  Alexander G Maier; Jake Baum; Brian Smith; David J Conway; Alan F Cowman
Journal:  Infect Immun       Date:  2009-02-09       Impact factor: 3.441

3.  Interaction of Salmonella typhi strains with cultured human monocyte-derived macrophages.

Authors:  D R Sizemore; E A Elsinghorst; L C Eck; A A Branstrom; D L Hoover; R L Warren; F A Rubin
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

4.  Merozoite surface protein 1 recognition of host glycophorin A mediates malaria parasite invasion of red blood cells.

Authors:  Michael R Baldwin; Xuerong Li; Toshihiko Hanada; Shih-Chun Liu; Athar H Chishti
Journal:  Blood       Date:  2015-03-16       Impact factor: 22.113

5.  Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.

Authors:  Y P Shi; S E Hasnain; J B Sacci; B P Holloway; H Fujioka; N Kumar; R Wohlhueter; S L Hoffman; W E Collins; A A Lal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies.

Authors:  P H Jakobsen; P M Heegaard; C Koch; K Wasniowska; M M Lemnge; J B Jensen; B K Sim
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Erythrocyte-binding antigens of Plasmodium falciparum are targets of human inhibitory antibodies and function to evade naturally acquired immunity.

Authors:  Kristina E M Persson; Freya J I Fowkes; Fiona J McCallum; Nimmo Gicheru; Linda Reiling; Jack S Richards; Danny W Wilson; Sash Lopaticki; Alan F Cowman; Kevin Marsh; James G Beeson
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

8.  Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.

Authors:  Kristina E M Persson; Fiona J McCallum; Linda Reiling; Nicole A Lister; Janine Stubbs; Alan F Cowman; Kevin Marsh; James G Beeson
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  Inhibitory humoral responses to the Plasmodium falciparum vaccine candidate EBA-175 are independent of the erythrocyte invasion pathway.

Authors:  Aida S Badiane; Amy K Bei; Ambroise D Ahouidi; Saurabh D Patel; Nichole Salinas; Daouda Ndiaye; Ousmane Sarr; Omar Ndir; Niraj H Tolia; Souleymane Mboup; Manoj T Duraisingh
Journal:  Clin Vaccine Immunol       Date:  2013-06-12

10.  Multiple Plasmodium falciparum Merozoite Surface Protein 1 Complexes Mediate Merozoite Binding to Human Erythrocytes.

Authors:  Clara S Lin; Alessandro D Uboldi; Christian Epp; Hermann Bujard; Takafumi Tsuboi; Peter E Czabotar; Alan F Cowman
Journal:  J Biol Chem       Date:  2016-01-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.